Edwards MITRIS RESILIA Valve Receives CE Mark for Mitral Replacement Surgeries

Contributed by: Business Wire

Images

The MITRIS RESILIA valve is made with innovative tissue technology RESILIA allowing the valve to potentially last longer than conventional bioprosthetic valves.* (Photo: Business Wire)
The MITRIS RESILIA valve is made with innovative tissue technology RESILIA allowing the valve to potentially last longer than conventional bioprosthetic valves.* (Photo: Business Wire)
The MITRIS RESILIA valve is made with innovative tissue technology RESILIA allowing the valve to potentially last longer than conventional bioprosthetic valves.* (Photo: Business Wire)
The MITRIS RESILIA valve is made with innovative tissue technology RESILIA allowing the valve to potentially last longer than conventional bioprosthetic valves.* (Photo: Business Wire)
Business Wire embedded0

Tags

Health
Medical Devices
Managed Care
Research
Science
Pharmaceutical
Biotechnology
CE mark

More Like This

Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability

Business Wire logo

ReValve Solutions Announces Successful First-in-Human with Next Generation TMVR Technology

PR Newswire associated0

Meril Life Sciences Presents One-year Outcomes from the LANDMARK Randomized Controlled Trial at PCR London Valves 2025

Business Wire logo

Edwards Launches SAPIEN 3 With Alterra Prestent in Europe for Transcatheter Pulmonic Valve Implantation

PR Newswire associated0

Meril Champions Innovation with Myval Octapro THV Launch at GISE 2024 & PCR LondonValves 2024

PR Newswire associated0

Meril Presents Successful LANDMARK RCT One-Year Results at Prestigious EuroPCR 2025

PR Newswire associated0

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study

MERIL Announces Successful Primary Outcomes of Next-Gen Myval THV Series in Major RCT, Presented at EuroPCR 2024 - Earns Prestigious Late Breaking Trial Status & The LANCET Acceptance